Phosphorus-based SAHA analogues as histone deacetylase inhibitors.

[structure: see text] Three analogues of suberoyl anilide hydroxamic acid (SAHA) with phosphorus metal-chelating functionalities were synthesized as inhibitors of histone deacetylases (HDACs). The compounds showed weak activity for HeLa nuclear extracts (IC(50) = 0.57-6.1 mM), HDAC8 (IC(50) = 0.28-0.41 mM), and histone-deacetylase-like protein (HDLP, IC(50) = 0.33-1.9 mM), suggesting that the transition state of HDAC is not analogous to zinc proteases. Antiproliferative activity against A2780 cancer cells (IC(50) = 0.11-0.12 mM), comparable to SAHA (0.15 mM), was observed.

[1]  P. Marks,et al.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.

[2]  J. Doly,et al.  Inhibition of Histone Deacetylation Induces Constitutive Derepression of the Beta Interferon Promoter and Confers Antiviral Activity , 2001, Journal of Virology.

[3]  Paul A. Bartlett,et al.  Differential binding energy: a detailed evaluation of the influence of hydrogen-bonding and hydrophobic groups on the inhibition of thermolysin by phosphorus-containing inhibitors , 1991 .

[4]  P. Liberator,et al.  Histone deacetylase: a target for antiproliferative and antiprotozoal agents. , 2001, Current medicinal chemistry.

[5]  G. Fantuzzi,et al.  The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Grunstein,et al.  HDA1 and HDA3 Are Components of a Yeast Histone Deacetylase (HDA) Complex* , 1996, The Journal of Biological Chemistry.

[7]  D M Schmatz,et al.  Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  V. Dive,et al.  Phosphinic peptides, the first potent inhibitors of astacin, behave as extremely slow-binding inhibitors. , 1998, The Biochemical journal.

[9]  P. Bartlett,et al.  A phosphonamidate dipeptide analog as an inhibitor of carboxypeptidase A , 1981 .

[10]  B. Matthews,et al.  Binding of hydroxamic acid inhibitors to crystalline thermolysin suggests a pentacoordinate zinc intermediate in catalysis. , 1982, Biochemistry.

[11]  P. Bartlett,et al.  Phosphonamidates as transition-state analogue inhibitors of thermolysin. , 1983, Biochemistry.

[12]  Stuart L Schreiber,et al.  Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. , 2002, Chemistry & biology.

[13]  R. S. Rogers,et al.  Phosphorus-containing inhibitors of endothelin converting enzyme: effects of the electronic nature of phosphorus on inhibitor potency. , 1993, Journal of medicinal chemistry.

[14]  P. Bartlett,et al.  Possible role for water dissociation in the slow binding of phosphorus-containing transition-state-analogue inhibitors of thermolysin. , 1987, Biochemistry.

[15]  P. Marks,et al.  Histone deacetylases and cancer: causes and therapies , 2001, Nature Reviews Cancer.

[16]  W. Malachowski,et al.  The Chemistry of Phosphapeptides: Formation of Functionalized Phosphonochloridates under Mild Conditions and Their Reaction with Alcohols and Amines , 1994 .

[17]  P. Jouin,et al.  (1H-Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium Hexafluorophosphate- and (1H-Benzotriazol-1-yloxy)tripyrrolidinophosphonium Hexafluorophosphate-Mediated Activation of Monophosphonate Esters: Synthesis of Mixed Phosphonate Diesters, the Reactivity of the Benzotriazolyl Phosphonic Esters vs th , 1995 .

[18]  J. Hanson,et al.  Phosphonate analogues of carboxypeptidase A substrates are potent transition-state analogue inhibitors. , 1989, Biochemistry.

[19]  J. Powers,et al.  Peptide hydroxamic acids as inhibitors of thermolysin. , 1978, Biochemistry.

[20]  J. Powers,et al.  Design of potent reversible inhibitors for thermolysin. Peptides containing zinc coordinating ligands and their use in affinity chromatography. , 1979, Biochemistry.

[21]  U. Weidle,et al.  Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment. , 2000, Anticancer research.

[22]  D. Moras,et al.  Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state. , 2001, Journal of molecular biology.

[23]  J. Powers,et al.  Inhibition of thermolysin and carboxypeptidase A by phosphoramidates. , 1979, Biochemistry.

[24]  R A Rifkind,et al.  Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.